AD
CMS Will Cover 80% of Leqembi Cost; No Trial Entry Needed
The FDA granted full traditional approval to the anti-amyloid Alzheimer’s disease drug Leqembi and CMS ...
SEPTEMBER 8, 2023
FDA Grants New Indication for Dupixent for Young Children With Atopic Dermatitis
The new indication for children ranging from 6 months to 5 years of age makes Dupixent the first biologic approved ...
JUNE 8, 2022
Abrocitinib Approved to Treat Severe Atopic Dermatitis
The FDA approved a new oral medication for the treatment of moderate to severe atopic dermatitis in adults whose ...
JANUARY 19, 2022
Atopic Dermatitis in the Specialty World
Therapy for atopic dermatitis (AD), a chronic inflammatory skin disease that usually starts in infancy or early ...
AUGUST 12, 2019
Load more